\-\ Texto\\:\\ \ \(0\)\
\-\ clinical\\ findings\\ of\\ sciatica\\.\\ bilateral\\,\\ asymmetric\\ sensory\\ deficits\\ and\\ motor\\ dysfunction\\ of\\ the\\ lower\\ extremity\\.\ \(0\)\
\-\ surgical\\ excision\\ of\\ the\\ tumor\\ with\\ regular\\ postoperative\\ follow\\ up\\.\ \(0\)\
\-\ during\\ postoperative\\ follow\\ up\\ at\\ a\\ 5\\ month\\ interval\\,\\ sagittal\\ and\\ axial\\ gadolinium\\-enhanced\\ t1\\-weighted\\ images\\ demonstrate\\ no\\ evidence\\ of\\ residual\\ disease\\ or\\ recurrence\\ of\\ the\\ tumor\\.\ \(0\)\
\-\ \\â\\€\\¢\\ sagittal\\ t1\\-weighted\\ mr\\ image\\ of\\ the\\ lumbar\\ spine\\ shows\\ a\\ well\\-defined\\ isointense\\ lesion\\ in\\ the\\ region\\ of\\ filum\\ terminale\\,\\ located\\ at\\ the\\ level\\ of\\ l1\\ vertebra\\.\ \(0\)\
\-\ \\â\\€\\¢\\ sagittal\\ t2\\-weighted\\ mr\\ image\\ shows\\ heterogeneous\\ hyperintense\\ nature\\ of\\ the\\ lesion\\.\ \(0\)\
\-\ \\â\\€\\¢\\ axial\\ t2\\-weighted\\ mr\\ image\\ reveals\\ the\\ central\\ location\\ of\\ the\\ lesion\\ within\\ the\\ cord\\ region\\.\ \(0\)\
\-\ \\â\\€\\¢\\ gadolinium\\-enhanced\\ sagittal\\ t1\\-weighted\\ mr\ \(0\)\
\-\ image\\ demonstrates\\ intense\\ enhancement\\ of\\ the\\ lesion\\.\ \(1\)\
\-\ myxopapillary\\ ependymoma\ \(2\)\
\-\ \\Â\\»\\ intramedullary\\:\ \(0\)\
\-\ \\â\\€\\¢\\ ependymomas\ \(0\)\
\-\ \\â\\€\\¢\\ astrocytomas\ \(0\)\
\-\ \\â\\€\\¢\\ hemangioblastomas\ \(0\)\
\-\ \\Â\\»\\ extramedullary\\-intradural\\:\ \(0\)\
\-\ \\â\\€\\¢\\ ependymoma\\ \\-\\ myxopapillary\\ type\ \(1\)\
\-\ \\â\\€\\¢\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ epdermoid\\/dermoid\ \(0\)\
\-\ \\â\\€\\¢\\ \\"drop\\"\\ metastasis\ \(0\)\
\-\ 60\\ year\\ old\\ man\\ presented\\ with\\ a\\ 2\\ years\\ history\\ of\\ chronic\\,\\ slowly\\ progressing\\ low\\ back\\ pain\\ and\\ bilateral\\ leg\\ numbness\\ and\\ weakness\\.\ \(1\)\
\-\ the\\ diagnosis\\ of\\ myxopapillary\\ ependymoma\\ was\\ delayed\\ because\\ symptoms\\ were\\ attributed\\ to\\ sciatica\\,\\ probably\\ due\\ to\\ the\\ known\\ degenerative\\ spine\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ myxopapillary\\:\\ 0\\.0959173021250765\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.09084141168671814\ \(0\)\
\-\ gadolinium\\-enhanced\\:\\ 0\\.07847701684450775\ \(0\)\
\-\ sciatica\\:\\ 0\\.07455947956810037\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.06794759476697691\ \(0\)\
\-\ sagittal\\:\\ 0\\.0658617710629252\ \(0\)\
\-\ ependymoma\\:\\ 0\\.055436026625909594\ \(0\)\
\-\ mr\\:\\ 0\\.0524676226463079\ \(0\)\
\-\ image\\:\\ 0\\.05157853461444639\ \(0\)\
\-\ postoperative\\:\\ 0\\.04797459731648734\ \(0\)\
\-\ epdermoid\\/dermoid\\:\\ 0\\.042587045526408206\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.041805623712409264\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.04067969312056431\ \(0\)\
\-\ extramedullary\\-intradural\\:\\ 0\\.039238508422253876\ \(0\)\
\-\ hemangioblastomas\\:\\ 0\\.03588997131809955\ \(0\)\
\-\ lesion\\:\\ 0\\.0336339174106368\ \(0\)\
\-\ ependymomas\\:\\ 0\\.03146344604334518\ \(0\)\
\-\ filum\\:\\ 0\\.031003010392116555\ \(0\)\
\-\ terminale\\:\\ 0\\.031003010392116555\ \(0\)\
\-\ l1\\:\\ 0\\.02890002454062938\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.028623896937537842\ \(0\)\
\-\ progressing\\:\\ 0\\.027234128471587207\ \(0\)\
\-\ spine\\:\\ 0\\.02718940624159756\ \(0\)\
\-\ follow\\:\\ 0\\.02623381132315395\ \(0\)\
\-\ attributed\\:\\ 0\\.02615614030098716\ \(0\)\
\-\ vertebra\\:\\ 0\\.025844360005636575\ \(0\)\
\-\ intramedullary\\:\\ 0\\.025551487436475055\ \(0\)\
\-\ drop\\:\\ 0\\.025411451026459343\ \(0\)\
\-\ axial\\:\\ 0\\.02356320266732243\ \(0\)\
\-\ region\\:\\ 0\\.023319818620669685\ \(0\)\
\-\ shows\\:\\ 0\\.022699262799312836\ \(0\)\
\-\ slowly\\:\\ 0\\.022420923449617682\ \(0\)\
\-\ up\\:\\ 0\\.022201421749316167\ \(0\)\
\-\ dysfunction\\:\\ 0\\.021994389115580593\ \(0\)\
\-\ probably\\:\\ 0\\.021994389115580593\ \(0\)\
\-\ intense\\:\\ 0\\.021860188322792788\ \(0\)\
\-\ sensory\\:\\ 0\\.02135782255697613\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.021239989450096135\ \(0\)\
\-\ residual\\:\\ 0\\.020486992490159978\ \(0\)\
\-\ isointense\\:\\ 0\\.020291777329107433\ \(0\)\
\-\ interval\\:\\ 0\\.020244181694117038\ \(0\)\
\-\ asymmetric\\:\\ 0\\.0200583542505045\ \(0\)\
\-\ bilateral\\:\\ 0\\.020036886273569508\ \(0\)\
\-\ numbness\\:\\ 0\\.01983569189688002\ \(0\)\
\-\ nature\\:\\ 0\\.01954025990097021\ \(0\)\
\-\ tumor\\:\\ 0\\.01924862127160204\ \(0\)\
\-\ regular\\:\\ 0\\.01903536763654757\ \(0\)\
\-\ deficits\\:\\ 0\\.018890065920425452\ \(0\)\
\-\ schwannoma\\:\\ 0\\.018854413228166406\ \(0\)\
\-\ degenerative\\:\\ 0\\.018714376818150694\ \(0\)\
\-\ recurrence\\:\\ 0\\.018009285452821808\ \(0\)\
\-\ 60\\:\\ 0\\.018009285452821808\ \(0\)\
\-\ lumbar\\:\\ 0\\.017554274752050306\ \(0\)\
\-\ motor\\:\\ 0\\.017239103148821315\ \(0\)\
\-\ hyperintense\\:\\ 0\\.01713845538600565\ \(0\)\
\-\ located\\:\\ 0\\.016991309456127833\ \(0\)\
\-\ excision\\:\\ 0\\.016943240224953107\ \(0\)\
\-\ delayed\\:\\ 0\\.01680183741190908\ \(0\)\
\-\ leg\\:\\ 0\\.01623283723965602\ \(0\)\
\-\ reveals\\:\\ 0\\.016150955315434895\ \(0\)\
\-\ meningioma\\:\\ 0\\.015874827712343356\ \(0\)\
\-\ cord\\:\\ 0\\.015686830532393243\ \(0\)\
\-\ metastasis\\:\\ 0\\.015452885634299161\ \(0\)\
\-\ weakness\\:\\ 0\\.015331455811731325\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.015179686747801959\ \(0\)\
\-\ extremity\\:\\ 0\\.015097386326775061\ \(0\)\
\-\ because\\:\\ 0\\.014442117471430182\ \(0\)\
\-\ location\\:\\ 0\\.014399554043013976\ \(0\)\
\-\ type\\:\\ 0\\.013916059074139663\ \(0\)\
\-\ back\\:\\ 0\\.013618677948538537\ \(0\)\
\-\ central\\:\\ 0\\.013582760178067435\ \(0\)\
\-\ disease\\:\\ 0\\.013495048707398108\ \(0\)\
\-\ known\\:\\ 0\\.01306304871721652\ \(0\)\
\-\ clinical\\:\\ 0\\.012701979710463787\ \(0\)\
\-\ during\\:\\ 0\\.012632894927168153\ \(0\)\
\-\ month\\:\\ 0\\.012384611308215504\ \(0\)\
\-\ years\\:\\ 0\\.012121947521828417\ \(0\)\
\-\ 5\\:\\ 0\\.012078069673643301\ \(0\)\
\-\ level\\:\\ 0\\.01189801462631368\ \(0\)\
\-\ chronic\\:\\ 0\\.011627969241096617\ \(0\)\
\-\ low\\:\\ 0\\.01147907271916135\ \(0\)\
\-\ presented\\:\\ 0\\.011252935434890865\ \(0\)\
\-\ at\\:\\ 0\\.01118611741866312\ \(0\)\
\-\ enhancement\\:\\ 0\\.011065163121367324\ \(0\)\
\-\ due\\:\\ 0\\.011015831656777003\ \(0\)\
\-\ \\:\\:\\ 0\\.010920529623098212\ \(0\)\
\-\ evidence\\:\\ 0\\.010823394122545302\ \(0\)\
\-\ symptoms\\:\\ 0\\.010288200371488594\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.010145579891941144\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.009950480685904555\ \(0\)\
\-\ man\\:\\ 0\\.009762955763719803\ \(0\)\
\-\ demonstrate\\:\\ 0\\.009499768798710341\ \(0\)\
\-\ diagnosis\\:\\ 0\\.009479320438552753\ \(0\)\
\-\ were\\:\\ 0\\.009373363945361937\ \(0\)\
\-\ lower\\:\\ 0\\.009284357823013829\ \(0\)\
\-\ demonstrates\\:\\ 0\\.00901749372779317\ \(0\)\
\-\ 2\\:\\ 0\\.008889393702949498\ \(0\)\
\-\ \\-\\:\\ 0\\.008848929752214317\ \(0\)\
\-\ findings\\:\\ 0\\.008786651863719611\ \(0\)\
\-\ the\\:\\ 0\\.008682322227763939\ \(0\)\
\-\ surgical\\:\\ 0\\.008677399856287215\ \(0\)\
\-\ images\\:\\ 0\\.007919149236470309\ \(0\)\
\-\ within\\:\\ 0\\.007875030958386868\ \(0\)\
\-\ of\\:\\ 0\\.0073166638182311575\ \(0\)\
\-\ \\,\\:\\ 0\\.006538890471432062\ \(0\)\
\-\ a\\:\\ 0\\.005747823214762337\ \(0\)\
\-\ history\\:\\ 0\\.005701519505831321\ \(0\)\
\-\ pain\\:\\ 0\\.005041585350390023\ \(0\)\
\-\ or\\:\\ 0\\.004838274149583128\ \(0\)\
\-\ was\\:\\ 0\\.004774287546926023\ \(0\)\
\-\ year\\:\\ 0\\.0046188660351348535\ \(0\)\
\-\ old\\:\\ 0\\.004226737182909442\ \(0\)\
\-\ no\\:\\ 0\\.004156735027554599\ \(0\)\
\-\ to\\:\\ 0\\.004126261917323538\ \(0\)\
\-\ and\\:\\ 0\\.003478434893376202\ \(0\)\
\-\ in\\:\\ 0\\.0020357354113055793\ \(0\)\
\-\ \\.\\:\\ 0\\.0017149534346544094\ \(0\)\
\-\ with\\:\\ 0\\.0011304751313032824\ \(0\)\
